You just read:

Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury

News provided by

Theravance Biopharma, Inc.

09 Apr, 2020, 12:00 BST